CHART INDUSTRIES, INC. (NASDAQ:GTLS) Files An 8-K Changes in Registrant’s Certifying Accountant

0
CHART INDUSTRIES, INC. (NASDAQ:GTLS) Files An 8-K Changes in Registrant’s Certifying Accountant

CHART INDUSTRIES, INC. (NASDAQ:GTLS) Files An 8-K Changes in Registrant’s Certifying Accountant
Item 4.01Change in Registrant’s Certifying Accountant.

(a)The Audit Committee (the “Audit Committee”) of the Board of Directors of Chart Industries, Inc. (the “Company”) conducted a comprehensive, competitive process to determine the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2019. On February 25, 2019, the Audit Committee approved the engagement of Deloitte & Touche LLP (“D&T”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2019, and the dismissal of Ernst & Young LLP (“EY”). The dismissal of EY is effective immediately.

EY’s audit reports on the Company’s consolidated financial statements as of and for the fiscal years ended December 31, 2018 and 2017 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles.

During the fiscal years ended December 31, 2018 and 2017, and during the subsequent interim period from January 1, 2019 through February 25, 2019, there were (i) no disagreements between the Company and EY on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, any of which, if not resolved to EY’s satisfaction, would have caused EY to make reference thereto in its reports, and (ii) no “reportable events” within the meaning of Item 304(a)(1)(v) of Regulation S-K.

The Company provided EY with a copy of disclosures it is making in this Form 8-K and requested that EY furnish a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements made herein. A copy of EY’s letter dated March 1, 2019, is filed as Exhibit 16.1 hereto.

(b)During the fiscal years ended December 31, 2018 and 2017, and during the subsequent interim period from January 1, 2019 through February 25, 2019, neither the Company nor anyone on its behalf has consulted with D&T regarding:

(i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report or oral advice was provided to the Company that D&T concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue,

(ii) any matter that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K, or

(iii) any reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.

Item 9.01Financial Statements and Exhibits.

(d)Exhibits.

Exhibit No.

Description

16.1

Letter of Ernst & Young LLP, dated March 1, 2019

CHART INDUSTRIES INC Exhibit
EX-16.1 2 exhibitto8-kxxletterfromey.htm EXHIBIT 16.1 Exhibit Exhibit 16.1[Ernst & Young LLP Letterhead]March 1,…
To view the full exhibit click here

About CHART INDUSTRIES, INC. (NASDAQ:GTLS)

Chart Industries, Inc. (Chart) is a diversified manufacturer of engineered equipment for the industrial gas, energy, and biomedical industries. The Company’s equipment and engineered systems are used for low-temperature and cryogenic applications. It operates through three segments, including Energy & Chemicals (E&C), Distribution & Storage (D&S), and BioMedical. The Company’s products include vacuum insulated containment vessels, heat exchangers, cold boxes, other cryogenic components and equipment for respiratory therapy. The Company’s E&C and D&S segment’s manufacture products used primarily in energy-related and industrial applications, such as the separation, liquefaction, distribution and storage of hydrocarbon and industrial gases. The Company, through its BioMedical segment, supplies cryogenic and other equipment used in respiratory healthcare and life sciences, including biological research and animal breeding.